Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy

References

• Klastersky J. Management of fever in neutropenic patients with different risks of complications. Clin Infect Dis 2004;39(Suppl. 1):S32–S37.
   PubMed Web of Science ®Google Scholar
• Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 2011;52:e56–e93.
   PubMed Web of Science ®Google Scholar
• Ramphal R. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis 2004;39(Suppl. 1):S25–S31.
   PubMed Web of Science ®Google Scholar
• Rybkine T, Mainardi JL, Sougakoff W, et al. Penicillin-binding protein 5 sequence alterations in clinical isolates of enterococcus faecium with different levels of beta-lactam resistance. J Infect Dis 1998;178:159–163.
   PubMed Web of Science ®Google Scholar
• Zscheck KK, Murray BE. Genes involved in the regulation of beta-lactamase production in enterococci and staphylococci. Antimicrob Agents Chemother 1993;37:1966–1970.
   PubMed Web of Science ®Google Scholar
• Rivera AM, Boucher HW. Current concepts in antimicrobial therapy against select gram-positive organisms: Methicillin-resistant staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci. Mayo Clin Proc 2011;86: 1230–1243.
   PubMed Web of Science ®Google Scholar
• Deshpande LM, Fritsche TR, Moet GJ, et al. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from north america and europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2007;58:163–170.
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39: 309–317.
   PubMed Web of Science ®Google Scholar
• Han SH, Chin BS, Lee HS, et al. Vancomycin-resistant enterococci bacteremia: Risk factors for mortality and influence of antimicrobial therapy on clinical outcome. J Infect 2009;58:182–190.
   PubMed Web of Science ®Google Scholar
• Vergis EN, Hayden MK, Chow JW, et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study. Ann Intern Med 2001; 135:484–492.
   PubMed Web of Science ®Google Scholar
• Erlandson KM, Sun J, Iwen PC, et al. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant enterococcus bacteremia. Clin Infect Dis 2008;46:30–36.
   PubMed Web of Science ®Google Scholar
• Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant enterococcus faecium bacteremia: Risk factors for infection. Clin Infect Dis 1995;20:1126–1133.
   PubMed Web of Science ®Google Scholar
• Weinstock DM, Conlon M, Iovino C, et al. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2007;13:615–621.
   PubMed Web of Science ®Google Scholar
• Bossaer JB, Hall PD, Garrett-Mayer E. Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. Support Care Cancer 2010; 19:231–237.
   PubMed Web of Science ®Google Scholar
• Matar MJ, Tarrand J, Raad I, et al. Colonization and infection with vancomycin-resistant enterococcus among patients with cancer. Am J Infect Control 2006;34:534–536.
   PubMed Web of Science ®Google Scholar
• Zaas AK, Song X, Tucker P, et al. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis 2002;35:1139–1146.
   PubMed Web of Science ®Google Scholar
• Tavadze M, Mossad S, Rybicki L, et al. Risk factors for vancomycin-resistant enterococcus (VRE) infection and its influence on survival in allogeneic hematopoietic progenitor cell transplantation (aHPCT). Blood 2012;120(Suppl. 1): Abstract 4147.
   Google Scholar
• Zirakzadeh A, Gastineau DA, Mandrekar JN, et al. Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2008;41:385–92.
   PubMed Web of Science ®Google Scholar
• Avery R, Kalaycio M, Pohlman B, et al. Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course. Bone Marrow Transplant 2005;35:497–499.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 2003;21:4642–4649.
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the world health organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114:937–951.
   PubMed Web of Science ®Google Scholar
• Mukjerhee S, Fu AZ, Mansour M, et al. Cigarette smoking significantly increases the risk of invasive fungal diease (IFD) in acute myeloid leukemia (AML) patients undergoing induction chemotherapy. Blood 2011;111(Suppl. 1): Abstract 3595.
   Google Scholar
• Worth LJ, Thursky KA, Seymour JF, et al. Vancomycin-resistant enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur J Haematol 2007;79:226–233.
   PubMed Web of Science ®Google Scholar
• Medeiros BC, Othus M, Estey EH, et al. Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia. Haematologica 2012;97:1401–1404.
   PubMed Web of Science ®Google Scholar
• Walter RB, Othus M, Borthakur G, et al. Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. J Clin Oncol 2011;29:4417–4423.
   PubMed Web of Science ®Google Scholar
• Linden PK, Pasculle AW, Manez R, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996; 22:663–70.
   PubMed Web of Science ®Google Scholar
• Garbutt JM, Ventrapragada M, Littenberg B, et al. Association between resistance to vancomycin and death in cases of enterococcus faecium bacteremia. Clin Infect Dis 2000;30:466–472.
   PubMed Web of Science ®Google Scholar
• Vydra J, Shanley RM, George I, et al. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012;55:764–770.
   PubMed Web of Science ®Google Scholar
• Bucaneve G, Micozzi A, Menichetti F, et al. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 2005;353:977–987.
   PubMed Web of Science ®Google Scholar
• Cullen M, Steven N, Billingham L, et al. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 2005;353:988–998.
   PubMed Web of Science ®Google Scholar
• Baden LR, Bensinger W, Angarone M, et al. Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw 2012;10:1412–1445.
   PubMed Web of Science ®Google Scholar
• Kamboj M, Cohen N, Gilhuley K, et al. Emergence of daptomycin-resistant VRE: experience of a single institution. Infect Control Hosp Epidemiol 2011;32:391–394.
   PubMed Web of Science ®Google Scholar
• Ramirez E, Gomez-Gil R, Borobia AM, et al. Improving linezolid use decreases the incidence of resistance among gram-positive microorganisms. Int J Antimicrob Agents 2013;41:174–178.
   PubMed Web of Science ®Google Scholar